{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:05:28Z","timestamp":1779555928296,"version":"3.53.1"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prp.2026.156542","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:44:39Z","timestamp":1779029079000},"page":"156542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring the cucurbitacins in neurofibromatosis: Molecular mechanisms and pharmacological potential"],"prefix":"10.1016","volume":"284","author":[{"given":"Varsha Senthil Kumar","family":"Buvaneswari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-7999","authenticated-orcid":false,"given":"Saranya","family":"Punniyakotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambasivam","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156542_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1\u2014a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2026.156542_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","author":"Rasmussen","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.prp.2026.156542_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/ncn3.12878","article-title":"Diagnostic importance of cutaneous manifestations of neurofibromatosis\u2014a systematic review","author":"Aslam","year":"2025","journal-title":"Neurol. Clin. Neurosci."},{"key":"10.1016\/j.prp.2026.156542_bib4","article-title":"Natural history and disease burden of neurofibromatosis type 1 with plexiform neurofibromas: a systematic literature review","volume":"12","author":"Copley-Merriman","year":"2021","journal-title":"Adolesc. Health Med. Ther."},{"key":"10.1016\/j.prp.2026.156542_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcna.2019.07.004","article-title":"The diagnosis and management of neurofibromatosis type 1","author":"Ly","year":"2019","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.prp.2026.156542_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-025-01054-9","article-title":"From benign neurofibromas to malignant peripheral nerve sheath tumors (MPNST): a gaming among multiple factors","author":"Yu","year":"2025","journal-title":"Cell. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib7","article-title":"The neurofibromatoses. An overview","volume":"20","author":"Ruggieri","year":"1999","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.prp.2026.156542_bib8","article-title":"Neurofibromatosis Type 1: from gene to population and cancer","volume":"1339","author":"Uusitalo","year":"2018","journal-title":"AnnUnivTurku"},{"key":"10.1016\/j.prp.2026.156542_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2018.11.008","article-title":"Complexity of genome sequencing and reporting: next generation sequencing (NGS) technologies and implementation of precision medicine in real life","author":"Morganti","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.prp.2026.156542_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100223","article-title":"Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review","author":"Solares","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.prp.2026.156542_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/13543784.2025.2558656","article-title":"Mirdametinib, an FDA-Approved MEK1\/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromas","author":"Oztosun","year":"2025","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.prp.2026.156542_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110788","article-title":"Vegetables from the Cucurbitaceae family and their products: Positive effect on human health","author":"Rolnik","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.prp.2026.156542_bib13","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1001306","article-title":"Overview of Cucurbitaceae Families","author":"Yiblet","year":"2023","journal-title":"Biol. Abiotic Stress Cucurbit Crops"},{"key":"10.1016\/j.prp.2026.156542_bib14","article-title":"Anticancer activity of cucurbitacins: in vitro evidence","author":"Singh","year":"2026","journal-title":"Bioact. Cucurbit. Ther. Benefits Toxic. Anal."},{"key":"10.1016\/j.prp.2026.156542_bib15","article-title":"Cucurbitacins as potential anticancer therapeutics: evidence from clinical trials and patents","author":"Alam","year":"2026","journal-title":"Bioact. Cucurbit. Ther. Benefits Toxic. Anal."},{"key":"10.1016\/j.prp.2026.156542_bib16","article-title":"Cucurbitacin B and cancer intervention: chemistry, biology and mechanisms (review)","author":"Garg","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2026.156542_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29174193","article-title":"Cucurbitacin B and its derivatives: a review of progress in biological activities","author":"Nie","year":"2024","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.prp.2026.156542_bib18","doi-asserted-by":"crossref","DOI":"10.2174\/1381612043452901","article-title":"Induction of Cytoprotective Genes Through Nrf2 \/ antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases","volume":"10","author":"Chen","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2026.156542_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/nov200","article-title":"Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis","author":"Blakeley","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.prp.2026.156542_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/children9010040","article-title":"Neurofibromatosis in children: actually and perspectives","author":"Sur","year":"2022","journal-title":"Children"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib21","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am. J. Med. Genet. Semin. Med. Genet."},{"issue":"9","key":"10.1016\/j.prp.2026.156542_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19931101)72:9<2746::AID-CNCR2820720936>3.0.CO;2-W","article-title":"Neurofibromatosis type 1 and childhood cancer","volume":"72","author":"Matsui","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2026.156542_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-012-0954-z","article-title":"Pathology of peripheral nerve sheath tumors: Diagnostic overview and update on selected diagnostic problems","author":"Rodriguez","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.prp.2026.156542_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S0046-8177(03)00349-6","article-title":"Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors","volume":"34","author":"Pylkk\u00e4nen","year":"2003","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2026.156542_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuchi.2015.03.012","article-title":"Natural history of vestibular schwannomas and hearing loss in NF2 patients","volume":"64","author":"Peyre","year":"2018","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.prp.2026.156542_bib26","article-title":"The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: a systematic review and meta-analysis","author":"Liu","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2026.156542_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s10689-025-00508-1","article-title":"Novel susceptibility genes for non-NF2-\/LZTR1-\/SMARCB1-related hereditary schwannomatosis","author":"Nogu\u00e9","year":"2025","journal-title":"Fam. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib28","article-title":"RAS and beyond: the many faces of the neurofibromatosis type 1 protein","volume":"15","author":"Anastasaki","year":"2022","journal-title":"DMM Dis. Models Mech."},{"key":"10.1016\/j.prp.2026.156542_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-020-01570-8","article-title":"Advancement in research and therapy of NF1 mutant malignant tumors","author":"Tao","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2026.156542_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-62017-1_32","article-title":"Neurofibromatosis Type I and Neurofibromatosis Type II","author":"Ronsley","year":"2024","journal-title":"Pediatr. Neuro-Oncol. 2nd Ed."},{"key":"10.1016\/j.prp.2026.156542_bib31","article-title":"Potential molecular biomarkers of vestibular schwannoma growth: progress and prospects","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156542_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2014.220","article-title":"Expanding the mutational spectrum of LZTR1 in schwannomatosis","volume":"23","author":"Paganini","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/02688697.2020.1836323","article-title":"What to know about schwannomatosis: a literature review","volume":"36","author":"Schraepen","year":"2022","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.prp.2026.156542_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s00439-016-1753-8","article-title":"The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis","author":"Kehrer-Sawatzki","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.prp.2026.156542_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0b013e3283541384","article-title":"Biological activities and potential molecular targets of cucurbitacins: a focus on cancer","author":"Chen","year":"2012","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.prp.2026.156542_bib36","doi-asserted-by":"crossref","DOI":"10.1210\/er.2017-00232","article-title":"The RASopathy family: consequences of germline activation of the RAS\/MAPK pathway","author":"Tajan","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2026.156542_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205059","article-title":"Progress on ras\/mapk signaling research and targeting in blood and solid cancers","author":"Dillon","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.prp.2026.156542_bib38","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-19-1017","article-title":"Nf1-mutant tumors undergo transcriptome and kinome remodeling after inhibition of either mTOR or MEK","volume":"19","author":"Pucciarelli","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"24","key":"10.1016\/j.prp.2026.156542_bib39","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7099","article-title":"Dual mTORC1\/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells","volume":"7","author":"Varin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2026.156542_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2015.125","article-title":"Role of Merlin\/NF2 inactivation in tumor biology","author":"Petrilli","year":"2016","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.prp.2026.156542_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30930","article-title":"PDLIM1 inhibits tumor metastasis through activating hippo signaling in hepatocellular carcinoma","volume":"71","author":"Huang","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010177","article-title":"Contribution of mTOR and PTEN to radioresistance in sporadic and NF2-associated vestibular schwannomas: A microarray and pathway analysis","volume":"12","author":"Gugel","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.prp.2026.156542_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/MAO.0000000000000788","article-title":"Tumor biology of vestibular schwannoma: a review of experimental data on the determinants of tumor genesis and growth characteristics","volume":"36","author":"De Vries","year":"2015","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.prp.2026.156542_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/febs.16091","article-title":"Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP\/TAZ","author":"Kwon","year":"2022","journal-title":"FEBS J."},{"issue":"12","key":"10.1016\/j.prp.2026.156542_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32855","article-title":"Low protein expression of LZTR1 in hepatocellular carcinoma triggers tumorigenesis via activating the RAS\/RAF\/MEK\/ERK signaling","volume":"10","author":"Ye","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2026.156542_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-020-01588-2","article-title":"Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance","author":"Yousefi","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2026.156542_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118156","article-title":"Hydrangea paniculata coumarins alleviate adriamycin-induced renal lipotoxicity through activating AMPK and inhibiting C\/EBP\u03b2","volume":"329","author":"Chen","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-05581-9","article-title":"Hydrangea paniculata coumarins attenuate experimental membranous nephritis by bidirectional interactions with the gut microbiota","volume":"6","author":"Li","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.prp.2026.156542_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153886","article-title":"Total coumarin derivates from Hydrangea paniculata attenuate renal injuries in cationized-BSA induced membranous nephropathy by inhibiting complement activation and interleukin 10-mediated interstitial fibrosis","volume":"96","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.prp.2026.156542_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14145071","article-title":"Neurofibromatosis Type 1 and MEK inhibition: a comprehensive review with focus on selumetinib therapy","author":"Imataka","year":"2025","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.prp.2026.156542_bib51","article-title":"Bevacizumab in Neurofibromatosis type 2 (NF2) related vestibular schwannomas: A nationally coordinated approach to delivery and prospective evaluation","volume":"3","author":"Morris","year":"2016","journal-title":"Neurooncol Pr."},{"key":"10.1016\/j.prp.2026.156542_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13237488","article-title":"Bevacizumab for Vestibular Schwannomas in Neurofibromatosis Type 2: a systematic review of tumor control and hearing preservation","author":"Screnci","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2026.156542_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-023-01388-3","article-title":"Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-associated vestibular schwannomas","author":"Cumpston","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156542_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biology14121772","article-title":"Major plant-based compounds for the prevention and treatment of melanoma\u2014a mini review","author":"Kirshteyn","year":"2025","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib55","article-title":"Clinical trials targeting neurofibromatoses-associated tumors: a systematic review","volume":"4","author":"Souza","year":"2022","journal-title":"Neurooncol Adv."},{"key":"10.1016\/j.prp.2026.156542_bib56","article-title":"Potential of cucurbitacin as an anticancer drug","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"JUN","key":"10.1016\/j.prp.2026.156542_bib57","article-title":"Curcumin induces apoptotic cell death via inhibition of PI3-kinase\/Akt pathway in B-precursor acute lymphoblastic leukemia","volume":"9","author":"Kuttikrishnan","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2026.156542_bib58","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-020-01660-7","article-title":"Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K\/Akt\/mTOR pathway: go four better to treat bladder cancer","author":"Khan","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2026.156542_bib59","article-title":"Cucurbitacins and cucurbitane glycosides: Structures and biological activities","author":"Jian","year":"2005","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.prp.2026.156542_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13101081","article-title":"Recent Advances in the Application of Cucurbitacins as Anticancer Agents","author":"Zieniuk","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.prp.2026.156542_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/foods14071200","article-title":"A comprehensive review of the nutritional and health-promoting properties of edible parts of selected cucurbitaceae plants","author":"Borecka","year":"2025","journal-title":"Foods"},{"issue":"3","key":"10.1016\/j.prp.2026.156542_bib62","doi-asserted-by":"crossref","DOI":"10.2174\/2215083808666220107104220","article-title":"Cucurbitacins: Nature\u2019s Wonder Molecules","volume":"8","author":"Kanani","year":"2022","journal-title":"Curr. Tradit. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-01170-2","article-title":"Critical enzymes for biosynthesis of cucurbitacin derivatives in watermelon and their biological significance","volume":"3","author":"Kim","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.prp.2026.156542_bib64","article-title":"Cucurbitacins - An insight into medicinal leads from nature","author":"Kaushik","year":"2015","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.prp.2026.156542_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ph15111325","article-title":"Pharmacokinetics and biological activity of cucurbitacins","author":"Delgado-Tiburcio","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib66","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-019-2568-7","article-title":"Pharmacokinetics of cucurbitacin B from Trichosanthes cucumerina L. in rats","volume":"19","author":"Hunsakunachai","year":"2019","journal-title":"BMC Complement Alter. Med"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2006.09.012","article-title":"Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells","volume":"73","author":"Tannin-Spitz","year":"2007","journal-title":"Biochem Pharm."},{"issue":"6","key":"10.1016\/j.prp.2026.156542_bib68","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156542_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061451","article-title":"Targeting the JAK\/STAT signaling pathway using phytocompounds for cancer prevention and therapy","author":"Bose","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib70","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2017.4547","article-title":"Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2\/STAT3 and MAPK pathways","volume":"14","author":"Zhang","year":"2017","journal-title":"Exp. Ther. Med"},{"issue":"4","key":"10.1016\/j.prp.2026.156542_bib71","doi-asserted-by":"crossref","DOI":"10.2174\/1574892818666230803100554","article-title":"Natural STAT3 inhibitors for cancer treatment: a comprehensive literature review","volume":"19","author":"Zarezadeh","year":"2023","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"27","key":"10.1016\/j.prp.2026.156542_bib72","doi-asserted-by":"crossref","DOI":"10.2174\/0929867325666180719122729","article-title":"Signal Transducer and Activator of Transcription Protein 3 (STAT3): an update on its direct inhibitors as promising anticancer agents","volume":"26","author":"Gelain","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.prp.2026.156542_bib73","doi-asserted-by":"crossref","DOI":"10.7150\/jca.65875","article-title":"Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2\/STAT3 signalling pathway in vivo and in vitro","volume":"13","author":"Xu","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2026.156542_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156542_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1476427","article-title":"Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implications","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.prp.2026.156542_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2017.99","article-title":"Cucurbitacin I inhibits STAT3, but enhances STAT1 signaling in human cancer cells in vitro through disrupting actin filaments","volume":"39","author":"Guo","year":"2018","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.prp.2026.156542_bib77","article-title":"Cucurbitacins: a focus on cucurbitacin E as a natural product and their biological activities","author":"Ramezani","year":"2021","journal-title":"Pharm. Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib78","doi-asserted-by":"crossref","DOI":"10.2174\/1574888X13666180301124935","article-title":"Signal Transduction through JAK-STAT and NF-\u03baB Regulated Pim-1 Kinase: novel target for anticancer leads","volume":"13","author":"Nandi","year":"2018","journal-title":"Curr. Signal Transduct. Ther."},{"key":"10.1016\/j.prp.2026.156542_bib79","article-title":"Cyclin B1 and CDK1: nuclear localization and upstream regulators","author":"Porter","year":"2003","journal-title":"Prog. Cell Cycle Res."},{"key":"10.1016\/j.prp.2026.156542_bib80","article-title":"Past, present, and future therapeutic strategies for NF-1-Associated Tumors","author":"Na","year":"2024","journal-title":"Curr. Oncol. Rep."},{"issue":"10","key":"10.1016\/j.prp.2026.156542_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-2952(96)00557-6","article-title":"Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells","volume":"52","author":"Duncan","year":"1996","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.prp.2026.156542_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.698192","article-title":"Neurofibromatosis: molecular pathogenesis and natural compounds as potential treatments","author":"Amaravathi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156542_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12081557","article-title":"The contribution of oxidative stress to NF1-Altered Tumors","author":"Kuhn","year":"2023","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.prp.2026.156542_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgq167","article-title":"Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway","volume":"31","author":"Dong","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2026.156542_bib85","article-title":"Cucurbitacins as potent chemo-preventive agents: mechanistic insight and recent trends","author":"Tuli","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156542_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155177","article-title":"Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing DNA damage-dependent cell cycle arrest","volume":"126","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.prp.2026.156542_bib87","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2023.12183","article-title":"Cucurbitacin B induces apoptosis in colorectal cells through reactive oxygen species generation and endoplasmic reticulum stress pathways","volume":"26","author":"Huang","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"24","key":"10.1016\/j.prp.2026.156542_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412022","article-title":"Cucurbitacin D induces apoptotic cell death via nox4 and overcomes radioresistance in colorectal cancer","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156542_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2010.08.004","article-title":"Protective effect of N-acetyl-l-cysteine against disulfiram-induced oxidative stress and apoptosis in V79 cells","volume":"248","author":"Grosicka-Maciag","year":"2010","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.prp.2026.156542_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.8454","article-title":"Multifaceted Therapeutic Impacts of Cucurbitacin B: recent evidences from preclinical studies","author":"Sahu","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.prp.2026.156542_bib91","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-014-1666-4","article-title":"Functional interplay between ATM\/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress","author":"Yan","year":"2014","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.prp.2026.156542_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111534","article-title":"Antitumor platinum(II) complex 56MESS binds to DNA G-quadruplexes, downregulates expression of c-MYC and k-RAS oncogenes, and triggers DNA damage in cancer cells","volume":"416","author":"Malina","year":"2025","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.prp.2026.156542_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpor.2020.04.010","article-title":"Molecular targets for NF1-associated malignant peripheral nerve sheath tumor","author":"Binobaid","year":"2020","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"10.1016\/j.prp.2026.156542_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.7045","article-title":"Antioxidant potential of family Cucurbitaceae with special emphasis on Cucurbita genus: a key to alleviate oxidative stress-mediated disorders","author":"Salehi","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.prp.2026.156542_bib95","doi-asserted-by":"crossref","DOI":"10.1080\/10409238.2021.1934811","article-title":"Cancer cells dysregulate PI3K\/AKT\/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses","author":"Cirone","year":"2021","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.prp.2026.156542_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041077","article-title":"Malignant peripheral nerve sheath tumors: latest concepts in disease pathogenesis and clinical management","author":"Yao","year":"2023","journal-title":"Cancers"},{"issue":"61","key":"10.1016\/j.prp.2026.156542_bib97","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21704","article-title":"Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K\/Akt\/mTOR, STAT3 and ERK signaling","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2026.156542_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104042","article-title":"Cucurbitacins: bioactivities and synergistic effect with small-molecule drugs","author":"Jing","year":"2020","journal-title":"J. Funct. Foods"},{"issue":"10","key":"10.1016\/j.prp.2026.156542_bib99","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14333","article-title":"Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK\/STAT3, MAPK\/ERK, and AKT\/mTOR signaling pathways in HepG2 cell line","volume":"46","author":"\u00dcremi\u015f","year":"2022","journal-title":"J. Food Biochem"},{"issue":"7","key":"10.1016\/j.prp.2026.156542_bib100","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-14-0182","article-title":"STAT3 and HIF1\u03b1 signaling drives oncogenic cellular phenotypes in malignant peripheral nerve sheath tumors","volume":"13","author":"Rad","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"24","key":"10.1016\/j.prp.2026.156542_bib101","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2026.156542_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4313204","article-title":"PTEN activation by DNA damage induces protective autophagy in response to Cucurbitacin B in hepatocellular carcinoma cells","volume":"2016","author":"Niu","year":"2016","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.prp.2026.156542_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.8166","article-title":"Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: a mechanistic insight","author":"Damare","year":"2024","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.prp.2026.156542_bib104","doi-asserted-by":"crossref","DOI":"10.1097\/MAO.0b013e3182956169","article-title":"Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: Cucurbitacin D and goyazensolide","volume":"34","author":"Spear","year":"2013","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.prp.2026.156542_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123327","article-title":"Regulation of cell cycle progression by growth factor-induced cell signaling","author":"Wang","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.prp.2026.156542_bib106","article-title":"Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS\/NO and inhibition of the Akt signalling pathway","volume":"39","author":"Zhang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156542_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/srep36594","article-title":"Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer","volume":"6","author":"Sikander","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib108","doi-asserted-by":"crossref","DOI":"10.3892\/or.2017.5648","article-title":"Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A\/PP2A\/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells","volume":"38","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156542_bib109","article-title":"Modulating the P53-MDM2 pathway: the therapeutic potential of natural compounds in cancer treatment","author":"Ramli","year":"2024","journal-title":"EXCLI J."},{"issue":"11","key":"10.1016\/j.prp.2026.156542_bib110","article-title":"Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK\/STAT3, PI3K\/Akt\/mTOR and MAPK Signaling Pathways","volume":"22","author":"Mehdi \u00dcremi\u015f","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib111","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-022-00581-z","article-title":"Cucurbitacin B inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K\/Akt\/mTOR pathways","volume":"17","author":"Yuan","year":"2022","journal-title":"Chin. Med."},{"issue":"11","key":"10.1016\/j.prp.2026.156542_bib112","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-014-1403-6","article-title":"Evaluating the anticancer properties of liposomal copper in a nude xenograft mouse model of human prostate cancer: Formulation, in vitro, in vivo, histology and tissue distribution studies","volume":"31","author":"Wang","year":"2014","journal-title":"Pharm. Res"},{"key":"10.1016\/j.prp.2026.156542_bib113","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160165","article-title":"Cucurbitacin E inhibits osteosarcoma cells proliferation and invasion through attenuation of PI3K\/AKT\/mTOR signalling pathway","author":"Wang","year":"2016","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2026.156542_bib114","doi-asserted-by":"crossref","DOI":"10.2174\/18715206113139990078","article-title":"Targeted Regulation of PI3K\/Akt\/mTOR\/NF-\u03baB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy","volume":"13","author":"Ahmad","year":"2013","journal-title":"Anticancer Agents Med Chem."},{"issue":"4","key":"10.1016\/j.prp.2026.156542_bib115","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10584","article-title":"Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells in vitro and in vivo by modulating multiple cellular pathways","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2026.156542_bib116","doi-asserted-by":"crossref","DOI":"10.1007\/s11418-015-0918-4","article-title":"Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells","volume":"69","author":"Ren","year":"2015","journal-title":"J. Nat. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib117","doi-asserted-by":"crossref","DOI":"10.53388\/TMR20190225102","article-title":"Advances in research on the anticancer mechanism of the natural compound cucurbitacin from Cucurbitaceae plants: a review","volume":"4","author":"Liang","year":"2019","journal-title":"Tradit. Med. Res."},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib118","doi-asserted-by":"crossref","DOI":"10.1142\/S0192415X15500226","article-title":"JSI-124 (Cucurbitacin I) inhibits tumor angiogenesis of human breast cancer through reduction of STAT3 phosphorylation","volume":"43","author":"Qi","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.prp.2026.156542_bib119","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/563652","article-title":"Protective and curative effects of the sea cucumber Holothuria atra extract against DMBA-induced Hepatorenal diseases in rats","volume":"2015","author":"Dakrory","year":"2015","journal-title":"Biomed. Res Int"},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.2910390224","article-title":"Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents","volume":"39","author":"Regenass","year":"1987","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2026.156542_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ph15111380","article-title":"Modulation of cytoskeleton, protein trafficking, and signaling pathways by metabolites from cucurbitaceae, ericaceae, and rosaceae plant families","author":"Patel","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.prp.2026.156542_bib122","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2014.2581","article-title":"Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells","volume":"10","author":"Zhang","year":"2014","journal-title":"Mol. Med Rep."},{"issue":"5","key":"10.1016\/j.prp.2026.156542_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062823","article-title":"Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT\/mTOR, ERK and JAK2\/STAT3 Pathway","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib124","article-title":"Anti-cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K\/Akt\/mTOR pathway: in vitro and in vivo studies","volume":"42","author":"Sun","year":"2018","journal-title":"Int J. Mol. Med"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib125","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-11-2263","article-title":"Dual inhibition of the PI3K\/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature","volume":"72","author":"Fokas","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156542_bib126","article-title":"Bioactive cucurbitacins: therapeutic benefits, toxicity, and analysis. bioactive cucurbitacins","author":"Ahamad","year":"2026","journal-title":"Ther. Benefits Toxic. Anal."},{"key":"10.1016\/j.prp.2026.156542_bib127","doi-asserted-by":"crossref","DOI":"10.1201\/9781003583356-14","article-title":"Cucurbitacin\u2019s toxicity in humans","author":"Bayrakdar","year":"2025","journal-title":"Bioact. Cucurbit"},{"issue":"23","key":"10.1016\/j.prp.2026.156542_bib128","doi-asserted-by":"crossref","DOI":"10.7150\/jca.31303","article-title":"Cucurbitacin E inhibits cellular proliferation and enhances the chemo-response in gastric cancer by suppressing AKt activation","volume":"10","author":"Si","year":"2019","journal-title":"J. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2026.156542_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70540","article-title":"Cucurbitacin-E-Glucoside Augments Tamoxifen\u2019s Anticancer Efficacy by Targeting PPAR\u03b3 and NF-kB: In Vivo and In Silico Studies","volume":"39","author":"Sabry","year":"2025","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.prp.2026.156542_bib130","series-title":"NSU Journal of Student Research","article-title":"First-Pass Metabolism and Its Effect on Bioavailability","author":"Ahmed","year":"2025"},{"key":"10.1016\/j.prp.2026.156542_bib131","doi-asserted-by":"crossref","DOI":"10.4103\/0028-3886.250697","article-title":"Peripheral nerve tumors in neurofibromatosis 1: An overview on management and indications for surgical treatment in our experience","author":"Garozzo","year":"2019","journal-title":"Neurol. India"},{"issue":"2","key":"10.1016\/j.prp.2026.156542_bib132","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.117.245613","article-title":"Drug distribution into peripheral nerve","volume":"365","author":"Liu","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"51","key":"10.1016\/j.prp.2026.156542_bib133","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21075","article-title":"PCW. BCRP expression in schwannoma, plexiform neurofibroma and MPNST","volume":"8","author":"de Vries","year":"2017","journal-title":"Oncotarget"},{"issue":"29","key":"10.1016\/j.prp.2026.156542_bib134","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-024-05608-y","article-title":"Metabolic fate of the natural anticancer agent cucurbitacin B: an LC\u2013MS\/MS-enabled profiling of its major phase I and II conjugates in vivo","volume":"416","author":"Liu","year":"2024","journal-title":"Anal. Bioanal. Chem."},{"issue":"10","key":"10.1016\/j.prp.2026.156542_bib135","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.9b00161","article-title":"A Bioreductive Prodrug of Cucurbitacin B Significantly Inhibits Tumor Growth in the 4T1 Xenograft Mice Model","volume":"10","author":"Suebsakwong","year":"2019","journal-title":"ACS Med Chem. Lett."},{"key":"10.1016\/j.prp.2026.156542_bib136","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S362244","article-title":"Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy","volume":"17","author":"Chen","year":"2022","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.prp.2026.156542_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119565","article-title":"Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage","volume":"586","author":"Bakar-Ates","year":"2020","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.prp.2026.156542_bib138","doi-asserted-by":"crossref","DOI":"10.1080\/17435889.2024.2440301","article-title":"Innovative nanocarrier systems for enhanced delivery of phyto-active compounds in cancer therapy","author":"Dwivedi","year":"2025","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.prp.2026.156542_bib139","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.prp.2026.156542_bib140","article-title":"Comparison of the pharmacokinetic profiles of three triterpenoids after oral administration of a cucurbitacin tablet and nanosuspension by UHPLC-MS\/MS","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.prp.2026.156542_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ph16070943","article-title":"Pharmacokinetics of curcumin delivered by nanoparticles and the relationship with antitumor efficacy: a systematic review","author":"Silvestre","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2026.156542_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109261","article-title":"Cucurbitacin E shows synergistic effect with sorafenib by inducing apoptosis in hepatocellular carcinoma cells and regulates Jak\/Stat3, ERK\/MAPK, PI3K\/Akt\/mTOR signaling pathways","volume":"198","author":"\u00dcremi\u015f","year":"2023","journal-title":"Steroids"},{"issue":"10","key":"10.1016\/j.prp.2026.156542_bib143","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrestox.5b00153","article-title":"Synergistic Antiproliferative Effects of a New Cucurbitacin B derivative and chemotherapy drugs on lung cancer cell line A549","volume":"28","author":"Marostica","year":"2015","journal-title":"Chem. Res Toxicol."},{"key":"10.1016\/j.prp.2026.156542_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(97)00033-1","article-title":"Gene directed enzyme prodrug therapy for cancer","author":"McNeish","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2026.156542_bib145","doi-asserted-by":"crossref","DOI":"10.1100\/tsw.2010.44","article-title":"Cucurbitacin: Ancient compound shedding new light on cancer treatment","author":"Lee","year":"2010","journal-title":"TheScientificWorldJournal"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib146","article-title":"Cucurbitacins: a promising target for cancer therapy","volume":"7","author":"Alghasham","year":"2013","journal-title":"Int. J. Health Sci. (Qassim)"},{"key":"10.1016\/j.prp.2026.156542_bib147","article-title":"Cucurbitacins in plant food","author":"Gry","year":"2006","journal-title":"TemaNord"},{"key":"10.1016\/j.prp.2026.156542_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106587","article-title":"Cucurbitacin B: a review of its pharmacology, toxicity, and pharmacokinetics","author":"Dai","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"20","key":"10.1016\/j.prp.2026.156542_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/plants11202711","article-title":"Vitro Sprouted Plantlets of Citrullus colocynthis (L.) schrad shown to possess interesting levels of cucurbitacins and other bioactives against pathogenic fungi","volume":"11","author":"Marzouk","year":"2022","journal-title":"Plants"},{"key":"10.1016\/j.prp.2026.156542_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01287","article-title":"vitro and in vivo antitumor activity of cucurbitacin C, a novel natural product from cucumber","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Pharm."},{"key":"10.1016\/j.prp.2026.156542_bib151","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2013.144","article-title":"Advances in the treatment of neurofibromatosis-associated tumours","author":"Lin","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156542_bib152","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.c.32151","article-title":"Targeted Therapies in Neurofibromatosis Type 1","author":"Sato","year":"2025","journal-title":"Am. J. Med. Genet. Part C Sem. Med. Genet."},{"issue":"4","key":"10.1016\/j.prp.2026.156542_bib153","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2016.3670","article-title":"Anticancer effect of cucurbitacin B on MKN-45 cells via inhibition of the JAK2\/STAT3 signaling pathway","volume":"12","author":"Xie","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.prp.2026.156542_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.26808","article-title":"Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway","volume":"119","author":"Ni","year":"2018","journal-title":"J. Cell Biochem."},{"issue":"4","key":"10.1016\/j.prp.2026.156542_bib155","doi-asserted-by":"crossref","DOI":"10.4161\/auto.18867","article-title":"Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apopt","volume":"8","author":"Zhang","year":"2012","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.prp.2026.156542_bib156","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-21526-0","article-title":"Cucurbitacin B suppresses glioblastoma via the STAT3\/ROS\/endoplasmic reticulum stress pathway","volume":"15","author":"Lv","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156542_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/cells14151207","article-title":"Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics","author":"Nigam","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156542_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2014.05.005","article-title":"Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer","volume":"219","author":"Kim","year":"2014","journal-title":"Chem. Biol. Inter."},{"issue":"3","key":"10.1016\/j.prp.2026.156542_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030364","article-title":"Cucurbitacin D reprograms glucose metabolic network in prostate cancer","volume":"11","author":"Sikander","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.prp.2026.156542_bib160","doi-asserted-by":"crossref","DOI":"10.2174\/1871520614666140601220915","article-title":"Cucurbitacin B Induces DNA Damage, G2\/M Phase Arrest, and Apoptosis Mediated by Reactive Oxygen Species (ROS) in Leukemia K562 Cells","volume":"14","author":"Guo","year":"2014","journal-title":"Anticancer Agents Med. Chem."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T16:44:59Z","timestamp":1779554699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":160,"alternative-id":["S0344033826001950"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156542","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the cucurbitacins in neurofibromatosis: Molecular mechanisms and pharmacological potential","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156542"}}